Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Treasury Shares (2017 - 2023)

Dianthus Therapeutics has reported Treasury Shares over the past 5 years, most recently at $63.0 for Q3 2023.

  • Quarterly results put Treasury Shares at $63.0 for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $63.0 (changed N/A YoY), and the annual figure for FY2022 was $16084.0, changed.
  • Treasury Shares for Q3 2023 was $63.0 at Dianthus Therapeutics, down from $16084.0 in the prior quarter.
  • Over the last five years, Treasury Shares for DNTH hit a ceiling of $205722.0 in Q4 2019 and a floor of $63.0 in Q3 2023.
  • Median Treasury Shares over the past 3 years was $16084.0 (2022), compared with a mean of $73956.3.
  • Peak annual rise in Treasury Shares hit 79.88% in 2019, while the deepest fall reached 79.88% in 2019.
  • Dianthus Therapeutics' Treasury Shares stood at $205722.0 in 2019, then tumbled by 92.18% to $16084.0 in 2022, then tumbled by 99.61% to $63.0 in 2023.
  • The last three reported values for Treasury Shares were $63.0 (Q3 2023), $16084.0 (Q4 2022), and $205722.0 (Q4 2019) per Business Quant data.